Difficulty: Medium
Average Score: 87%
Testbank
A patient has just been diagnosed with type 2 diabetes. The physician has prescribed an oral antidiabetic agent that will inhibit the production of glucose by the liver and thereby aid in the control of blood glucose. What type of oral antidiabetic agent did the physician prescribe for this patient?
Correct answer
B
Rationale
B: A biguanide
Biguanides, such as metformin, work primarily by reducing hepatic glucose production, which helps to control blood glucose levels in patients with type 2 diabetes. This mechanism aligns with the physician's goal of managing the patient's newly diagnosed condition effectively.
A: A sulfonylurea
Sulfonylureas stimulate insulin secretion from the pancreas, which does not directly inhibit liver glucose production. This mechanism does not align with the treatment goal presented in the stem.
C: A thiazolidinedione
Thiazolidinediones improve insulin sensitivity in peripheral tissues rather than directly inhibiting glucose production by the liver. Therefore, this option does not match the specific action required for this patient.
D: An alpha glucosidase inhibitor
Alpha glucosidase inhibitors delay carbohydrate absorption in the intestines, which does not address the liver's glucose production. This option does not fit the context of controlling blood glucose through liver inhibition.
Biguanides, such as metformin, work primarily by reducing hepatic glucose production, which helps to control blood glucose levels in patients with type 2 diabetes. This mechanism aligns with the physician's goal of managing the patient's newly diagnosed condition effectively.
A: A sulfonylurea
Sulfonylureas stimulate insulin secretion from the pancreas, which does not directly inhibit liver glucose production. This mechanism does not align with the treatment goal presented in the stem.
C: A thiazolidinedione
Thiazolidinediones improve insulin sensitivity in peripheral tissues rather than directly inhibiting glucose production by the liver. Therefore, this option does not match the specific action required for this patient.
D: An alpha glucosidase inhibitor
Alpha glucosidase inhibitors delay carbohydrate absorption in the intestines, which does not address the liver's glucose production. This option does not fit the context of controlling blood glucose through liver inhibition.